Lori D. Lawley

Insider Reports History

Entity
Individual
Location
C/O Newlink Genetics Corporation, 2503 South Loop Drive, Ames, IA
Signature
/s/ Ryan Trytten, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lori D. Lawley:

Stock Role Class Num Shares Value Price $ Report Date Ownership
LUMOS PHARMA, INC. Chief Financial Officer Common Stock 12.3K $22K $1.79 Aug 1, 2024 Direct
LUMOS PHARMA, INC. Chief Financial Officer Stock Option (Right to Buy) 12K Apr 1, 2024 Direct

Insider Reports Filed by Lori D. Lawley

Symbol Company Period Transactions Value $ Form Type Date Filed Role
(LUMO) LUMOS PHARMA, INC. Aug 1, 2024 1 -$410 4 Aug 5, 2024 Chief Financial Officer
(LUMO) LUMOS PHARMA, INC. Apr 1, 2024 3 $2.06K 4 Apr 3, 2024 Chief Financial Officer
(LUMO) LUMOS PHARMA, INC. Feb 1, 2024 1 -$647 4 Feb 5, 2024 Chief Financial Officer
LUMO LUMOS PHARMA, INC. Aug 1, 2023 1 -$751 4 Aug 3, 2023 Chief Financial Officer
LUMO LUMOS PHARMA, INC. Apr 1, 2023 1 -$907 4 Apr 4, 2023 Chief Financial Officer
LUMO LUMOS PHARMA, INC. Feb 1, 2023 3 $3.12K 4 Feb 3, 2023 Chief Financial Officer
LUMO LUMOS PHARMA, INC. Aug 1, 2022 1 -$1.87K 4 Aug 3, 2022 Chief Financial Officer
LUMO LUMOS PHARMA, INC. Apr 1, 2022 1 -$2.53K 4 Apr 5, 2022 Chief Financial Officer
LUMO LUMOS PHARMA, INC. Feb 1, 2022 3 $9.37K 4 Feb 3, 2022 Chief Financial Officer
LUMO LUMOS PHARMA, INC. Aug 1, 2021 2 $0 4 Aug 3, 2021 Chief Financial Officer